Bachem Holding AG

Swiss Stock Exchange BANB.SW

Bachem Holding AG Net Income Margin for the year ending December 31, 2023: 19.38%

Bachem Holding AG Net Income Margin is 19.38% for the year ending December 31, 2023, a 2.33% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

Bachem Holding AG Net Income Margin for the year ending December 31, 2022 was 18.93%, a -16.91% change year over year.
Bachem Holding AG Net Income Margin for the year ending December 31, 2021 was 22.79%, a 17.36% change year over year.
Bachem Holding AG Net Income Margin for the year ending December 31, 2020 was 19.42%, a 12.47% change year over year.
Bachem Holding AG Net Income Margin for the year ending December 31, 2019 was 17.27%, a 4.57% change year over year.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

Swiss Stock Exchange: BANB.SW

Bachem Holding AG

CEO	Mr. Thomas Meier
IPO Date	July 17, 1998
Location	Switzerland
Headquarters	Hauptstrasse 144
Employees	2,009
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.

Key trends

Past 5 years